News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
730,540 Results
Type
Article (43551)
Company Profile (298)
Press Release (686681)
Multimedia
Podcasts (90)
Webinars (17)
Section
Business (206493)
Career Advice (2074)
Deals (35727)
Drug Delivery (118)
Drug Development (83092)
Employer Resources (174)
FDA (16681)
Job Trends (15078)
News (350326)
Policy (33146)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2637)
Accelerated approval (31)
Adcomms (27)
Allergies (140)
Alliances (50100)
ALS (170)
Alzheimer's disease (1696)
Antibody-drug conjugate (ADC) (317)
Approvals (16935)
Artificial intelligence (511)
Autoimmune disease (152)
Automation (38)
Bankruptcy (365)
Best Places to Work (11716)
BIOSECURE Act (21)
Biosimilars (192)
Biotechnology (190)
Bladder cancer (159)
Brain cancer (56)
Breast cancer (644)
Cancer (4843)
Cardiovascular disease (408)
Career advice (1754)
Career pathing (35)
CAR-T (282)
CDC (46)
Celiac Disease (2)
Cell therapy (750)
Cervical cancer (37)
Clinical research (70851)
Collaboration (1698)
Company closure (4)
Compensation (1139)
Complete response letters (58)
COVID-19 (2798)
CRISPR (90)
C-suite (821)
Cystic fibrosis (147)
Data (6192)
Decentralized trials (2)
Denatured (30)
Depression (141)
Diabetes (514)
Diagnostics (6747)
Digital health (44)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (247)
Drug pricing (191)
Drug shortages (29)
Duchenne muscular dystrophy (226)
Earnings (90669)
Editorial (57)
Employer branding (21)
Employer resources (152)
Events (118142)
Executive appointments (968)
FDA (19784)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (10)
Frontotemporal dementia (23)
Funding (1470)
Gene editing (198)
Generative AI (43)
Gene therapy (595)
GLP-1 (1028)
Government (4751)
Grass and pollen (6)
Guidances (384)
Healthcare (19015)
HIV (58)
Huntington's disease (48)
IgA nephropathy (84)
Immunology and inflammation (262)
Immuno-oncology (57)
Indications (103)
Infectious disease (3067)
Inflammatory bowel disease (194)
Inflation Reduction Act (16)
Influenza (112)
Intellectual property (244)
Interviews (323)
IPO (16695)
IRA (51)
Job creations (3699)
Job search strategy (1468)
JPM (56)
Kidney cancer (15)
Labor market (83)
Layoffs (570)
Leadership (30)
Legal (8017)
Liver cancer (94)
Longevity (14)
Lung cancer (661)
Lymphoma (375)
Machine learning (42)
Management (59)
Manufacturing (788)
MASH (164)
Medical device (13867)
Medtech (13919)
Mergers & acquisitions (20091)
Metabolic disorders (1307)
Multiple sclerosis (158)
NASH (20)
Neurodegenerative disease (319)
Neuropsychiatric disorders (93)
Neuroscience (2941)
Neurotech (1)
NextGen: Class of 2026 (6604)
Non-profit (4549)
Now hiring (65)
Obesity (620)
Opinion (269)
Ovarian cancer (165)
Pain (203)
Pancreatic cancer (226)
Parkinson's disease (283)
Partnered (35)
Patents (492)
Patient recruitment (474)
Peanut (56)
People (59272)
Pharmaceutical (66)
Pharmacy benefit managers (29)
Phase 1 (21900)
Phase 2 (31072)
Phase 3 (23440)
Pipeline (5099)
Policy (282)
Postmarket research (2684)
Preclinical (9321)
Press Release (66)
Prostate cancer (242)
Psychedelics (50)
Radiopharmaceuticals (279)
Rare diseases (836)
Real estate (6019)
Recruiting (70)
Regulatory (24771)
Reports (51)
Research institute (2427)
Resumes & cover letters (355)
Rett syndrome (28)
RNA editing (19)
RSV (79)
Schizophrenia (151)
Series A (246)
Series B (188)
Service/supplier (13)
Sickle cell disease (97)
Special edition (22)
Spinal muscular atrophy (162)
Sponsored (41)
Startups (3686)
State (2)
Stomach cancer (18)
Supply chain (105)
Tariffs (86)
The Weekly (58)
Vaccines (1025)
Venture capital (89)
Weight loss (414)
Women's health (87)
Worklife (18)
Date
Last 7 days (599)
Last 30 days (2112)
Last 365 days (30110)
2026 (2848)
2025 (30547)
2024 (35588)
2023 (40490)
2022 (51575)
2021 (56099)
2020 (54434)
2019 (46991)
2018 (35425)
2017 (32515)
2016 (32013)
2015 (38045)
2014 (31812)
2013 (26861)
2012 (29088)
2011 (29758)
2010 (27945)
Location
Africa (761)
Alabama (83)
Alaska (7)
Arizona (307)
Arkansas (13)
Asia (39902)
Australia (6582)
California (11233)
Canada (3261)
China (1105)
Colorado (475)
Connecticut (470)
Delaware (332)
Europe (86622)
Florida (1661)
Georgia (355)
Hawaii (3)
Idaho (62)
Illinois (859)
India (65)
Indiana (517)
Iowa (22)
Japan (417)
Kansas (127)
Kentucky (38)
Louisiana (26)
Maine (72)
Maryland (1373)
Massachusetts (8049)
Michigan (321)
Minnesota (628)
Mississippi (6)
Missouri (126)
Montana (31)
Nebraska (28)
Nevada (121)
New Hampshire (80)
New Jersey (2975)
New Mexico (28)
New York (2957)
North Carolina (1437)
North Dakota (9)
Northern California (5469)
Ohio (331)
Oklahoma (21)
Oregon (43)
Pennsylvania (2258)
Puerto Rico (22)
Rhode Island (47)
South America (1131)
South Carolina (65)
South Dakota (1)
Southern California (4368)
Tennessee (172)
Texas (1732)
United States (39780)
Utah (333)
Vermont (1)
Virginia (258)
Washington D.C. (82)
Washington State (919)
West Virginia (4)
Wisconsin (107)
Wyoming (2)
730,540 Results for "comparative biosciences inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Neurocrine Biosciences Presents Head-to-Head INGREZZA® (valbenazine) Capsules Data Demonstrating Higher VMAT2 Target Occupancy Compared to AUSTEDO XR
January 16, 2026
·
14 min read
Press Releases
Revelation Biosciences Inc. Announces Exercise of Warrants for $11 Million in Gross Proceeds
January 26, 2026
·
5 min read
Press Releases
Pulse Biosciences, Inc. Appoints Maria Sainz to its Board of Directors
January 9, 2026
·
3 min read
Press Releases
Revelation Biosciences Inc. Announces 1-for-4 Reverse Stock Split Effective January 28, 2026
January 27, 2026
·
5 min read
Press Releases
Ollin Biosciences Announces Positive Topline Data with Superior Outcomes from a Randomized Head-to-Head Study of OLN324 Compared to Faricimab (Vabysmo®) in Diabetic Macular Edema and Wet Age-Related Macular Degeneration
January 9, 2026
·
6 min read
Press Releases
Revelation Biosciences Inc. to Present at The International Conference on Advances in Critical Care Nephrology (AKI & CRRT 2026)
January 15, 2026
·
6 min read
Press Releases
Xenetic Biosciences, Inc. Announces Adjournment of 2025 Annual Meeting
December 12, 2025
·
7 min read
Press Releases
PURE Bioscience, Inc. Announces Leadership Promotions
November 20, 2025
·
3 min read
Press Releases
Innovent’s Partner Ollin Biosciences Announces Positive Topline Data with Superior Outcomes from a Randomized Head-to-Head Study of IBI324 Compared to Faricimab (Vabysmo®) in Diabetic Macular Edema and Wet Age-Related Macular Degeneration
January 9, 2026
·
8 min read
Press Releases
Xenetic Biosciences, Inc. Reports Third Quarter 2025 Financial Results
November 14, 2025
·
8 min read
1 of 73,054
Next
